Muscle Development and Regeneration The nicotinamide adenine dinucleotide (NAD+)-dependent deacetylase SIRT1 been shown to control skeletal muscle differentiation in a cell culture system. SIRT1 forms a complex with the acetyltransferases PCAF and p300 and the developmental regulator MyoD and, when overexpressed, retards muscle differentiation. Conversely, cells with decreased SIRT1 protein levels, or with enzymatic activity of SIRT1 is specifically inhibited by pharmacological agents, differentiate prematurely. We propose to investigate whether SIRT1 controls muscle differentiation in the animal. Muscle differentiation in vivo occurs during development, in the formation of new muscles, and in the adult, during regeneration following muscle injury. Understanding the role of SIRT1 during muscle development and muscle regeneration might have implications for the therapy of muscle wasting (i.e., muscle dystrophies, muscle healing following traumatic injuries, and sarcopenia of the elderly). Muscle Atrophy Skeletal muscle wasting and weakness (atrophy) is associated with numerous conditions, including the muscular dystrophies, disuse, burns, denervation, and cancer. A reduction of muscle mass and function is physiologically observed in the elderly (sarcopenia). As skeletal muscle mass is maintained through a balance of protein synthesis and degradation, a clearer understanding of these pathways may lead to novel treatment strategies for conditions where muscle wasting and weakness are described. Increased levels of the protein SIRT1 has previously been linked to increased lifespan in mice. In addition, SIRT1 has been found to decrease the expression of a number of proteins believed to be associated with skeletal muscle atrophy. However, no study to date has examined the role of SIRT1 in an animal model of muscle atrophy. The results from these experiments will provide novel and important results relating to the potential therapeutic applications of SIRT1 activation. Furthermore, these results will have implications for numerous conditions where muscle wasting and weakness are indicated.

Project Start
Project End
Budget Start
Budget End
Support Year
6
Fiscal Year
2013
Total Cost
$934,019
Indirect Cost
Name
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Department
Type
DUNS #
City
State
Country
Zip Code
Yang, Xiang-Ping; Jiang, Kan; Hirahara, Kiyoshi et al. (2015) EZH2 is crucial for both differentiation of regulatory T cells and T effector cell expansion. Sci Rep 5:10643
Ryall, James G; Dell'Orso, Stefania; Derfoul, Assia et al. (2015) The NAD(+)-dependent SIRT1 deacetylase translates a metabolic switch into regulatory epigenetics in skeletal muscle stem cells. Cell Stem Cell 16:171-83
Ryall, James G; Cliff, Tim; Dalton, Stephen et al. (2015) Metabolic Reprogramming of Stem Cell Epigenetics. Cell Stem Cell 17:651-62
Vahedi, Golnaz; Kanno, Yuka; Sartorelli, Vittorio et al. (2013) Transcription factors and CD4 T cells seeking identity: masters, minions, setters and spikers. Immunology 139:294-8
Roychoudhuri, Rahul; Hirahara, Kiyoshi; Mousavi, Kambiz et al. (2013) BACH2 represses effector programs to stabilize T(reg)-mediated immune homeostasis. Nature 498:506-10
Proserpio, Valentina; Fittipaldi, Raffaella; Ryall, James G et al. (2013) The methyltransferase SMYD3 mediates the recruitment of transcriptional cofactors at the myostatin and c-Met genes and regulates skeletal muscle atrophy. Genes Dev 27:1299-312
Kieffer-Kwon, Kyong-Rim; Tang, Zhonghui; Mathe, Ewy et al. (2013) Interactome maps of mouse gene regulatory domains reveal basic principles of transcriptional regulation. Cell 155:1507-20
Gabay, Odile (2012) Osteoarthritis: New Perspectives. J Spine 1:
Vahedi, Golnaz; Takahashi, Hayato; Nakayamada, Shingo et al. (2012) STATs shape the active enhancer landscape of T cell populations. Cell 151:981-93
Baur, Joseph A; Chen, Danica; Chini, Eduardo N et al. (2010) Dietary restriction: standing up for sirtuins. Science 329:1012-3; author reply 1013-4

Showing the most recent 10 out of 13 publications